Tiziana Announces Positive Clinical Data from A Secondary Progressive Multiple Sclerosis Patient Treated for Six Months with Intranasally Administered Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody
Intranasal foralumab was well-tolerated with no adverse reactions or laboratory abnormalities after 6 months of…
HKTDC’s ‘Hong Kong Tech Pavilion’ at Paris VivaTech 2026 to showcase 24 Hong Kong startups to connect global investment opportunities
C.banner to Acquire Controlling Stake in Benyuan Zhishu to Establish Dual-core Businesses: Footwear + AI Data
Megafurniture.sg Brings Furniture Manufacturing In-House With New Factories in Batu Pahat and Foshan, Producing Mattresses, Sofas and Bed Frames
Liplyn Group Brings International News Outlets and Job Platforms Together Under the Drimble Brand
iHerb Expands Consumer Benefits Across Asia with 618 Shopping Festival